" I try to focus on biotechs with solid science platforms, advancing clinical candidates and strong mgt.", you said in message 17.
Look a little closer at Nortran before you jump to conclusions.
1 Search a little in the scientific literature and you will find that our science is well established; search a little in a patent database and you will find that our patents meet high standards.
2 Search a little in a pharmaceutical industry intelligence database and you will find that there are very few, if any, projects in our industry which appear to be directly competitive with Nortran.
3 Read our news releases on nortran.com and learn that the last volunteer from our clinical trial of RSD921 was discharged and the trial is over, safely and successfully.
4 "Strong management" is important to you, as it is to us. Read our financials, again at nortran.com, and tell me whether you really think we have mismanaged in any way, considering how far we have progressed and how little money we have spent (and maybe compare us to many other "biotechs" in this respect).
As we move forward with our vision of discovering new drugs, I sincerely hope that influential people like you read, study, and ask before you judge.
Nortran is located in Vancouver, Canada. We are trading on the VSE. Our symbol is NRT, and soon to be NTRDF on the NASD Bulletin Board. Investors and brokers are invited to call the company at 1-800-330-9928.
Mr. Silverman, please respond and set the record straight.
Allen |
